Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | LDHA | P00338 | 1/20 | 0.36 |
| ▸ | LDHB | P07195 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | FYN | P06241 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5691942 | 1.00 | CA1 (0.36) | CA1CA2CA9LDHALDHB | |
| SCHEMBL5691946 | 1.00 | CA1 (0.36) | CA1CA2CA9LDHALDHB | |
| SCHEMBL9812383 | 0.82 | — | — | |
| SCHEMBL11106261 | 0.76 | — | — | |
| SCHEMBL11120424 | 0.76 | — | — | |
| SCHEMBL11120423 | 0.76 | — | — | |
| SCHEMBL30876328 | 0.76 | — | — | |
| SCHEMBL3675635 | 0.74 | — | — | |
| SCHEMBL29245273 | 0.72 | — | — | |
| SCHEMBL30104 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150273396-A1 | DRAW SOLUTIONS AND DRAW SOLUTE RECOVERY FOR OSMOTICALLY DRIVEN MEMBRANE PROCESSES | OASYS WATER, INC. | 2015-10-01 | — | — | US | disclosed |
| CN-101098691-B | Andrographolide derivatives to treat viral infections | CORNELL RES FOUNDATION INC | 2012-09-05 | — | — | CN | disclosed |
| CN-101098691-A | Andrographolide derivatives to treat viral infections | CORNELL RES FOUNDATION INC (US) | 2008-01-02 | — | — | CN | disclosed |